MarginsXMarginsX
Home › Markets › Health Care › TLSI

TriSalus Life Sciences Inc. (TLSI)

TLSI trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.27
-6.58% on the day
Market cap
$140.1M
Micro cap
Revenue · 2025
$45.2M
+53.4% on 2024
Net income · 2025
-$39.2M
-86.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1826667/000162828026015163/0001628280-26-015163-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTLSI on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2021
SEC CIK0001826667
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$45.2M
Net income-$39.2M
Operating income-$26.9M
Net margin-86.9%
Operating margin-59.7%
Revenue growth+53.4%
Cash$20.4M
Total assets$35.3M
P/E (computed)Net income was not positive
P/S (computed)3.1×

Warning signs

Cash runway
20.2 months
$41.1M cash at September 30, 2026
Share count, 1 year
+23.5%
2025-11-10 to 2026-11-06 · +134.4% over 3 years
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
$3.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$41.1M cash; operating cash flow -$6.1M a quarter.Report 2026-09-30
Shares outstanding61,699,034 (2026-11-06); 49,964,311 a year earlier; 26,316,681 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-02-26
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrant Thornton LLP, Chicago, Illinois, United StatesPCAOB Form AP 2026-03-11
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $3.5M, sold $136K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$12.9M-$8.9M-$5.3M$41.1M$32.4M$46.4M10-Q 2026-11-10
Q2 2026
2026-06-30
$11.4M-$9.2M-$10.1M$46.3M$33.1M$45.1M10-Q 2026-08-06
Q1 2026
2026-03-31
$8.9M$1.5M-$6.5M$56.6M$33.1M$44.9M10-Q 2026-05-12
Q4 2025
2025-12-31
$13.2M-$9.8M-$2.5M$20.4M$33.0M$45.2M10-K 2026-03-05
Q3 2025
2025-09-30
$11.6M-$10.8M-$3.7M$22.7M$32.8M$40.2M10-Q 2026-11-10
Q2 2025
2025-06-30
$11.2M-$8.3M-$7.3M$26.5M$32.3M$36.0M10-Q 2026-08-06
Q1 2025
2025-03-31
$9.2M-$10.4M-$4.5M$13.0M$31.7M$32.1M10-Q 2026-05-12
Q4 2024
2024-12-31
$8.3M-$10.1M-$5.7M$8.5M$22.1M$29.4M10-K 2026-03-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-02-26
Latest annual report10-K2026-03-05
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-10
Latest proxyDEFA14A2026-03-31

Source: SEC EDGAR submissions feed, 497 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-25.2%
1 month-39.2%
3 months-56.8%
Year to date-65.2%
1 year-44.6%
From 52-week high-67.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
TLSIWTriSalus Life Sciences Inc. Warrant$0.9330

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
BNRBurning Rock Biotech Limited$12.74-4.43%$134.4M
KEQUKewaunee Scientific Corporation$35.05-1.81%$101.5M
BDSXBiodesix Inc.$9.00-8.91%$99.8M
XGNExagen Inc.$3.77-8.72%$96.2M
SERASera Prognostics Inc.$1.94-3.48%$77.2M
YDESYD Bio Limited$4.83-1.02%$342.1M
FLGTFulgent Genetics Inc.$24.07-2.37%$672.6M
CSTLCastle Biosciences Inc.$32.75-3.08%$1.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier